Advertisement

The Accusations Against Vaccinations on the Internet: Autism, Mercury and Immunological Overload

  • Andrea Grignolio
Chapter

Abstract

Data, harsh data, are the only thing that count, we could say, paraphrasing a famous quotation from Stendhal’s The Red and the Black about the truth. At a time like the present, when we are submerged by information by media, it is not at all easy to find our way around to distinguish between what is true and what is false, in the sense of reported untruthfully or partially, or even fictive, in the sense of fake or fabricated. For my generation, which saw it come into being, the Internet has been and is a marvellous opportunity of cultural growth. Its strength lies in the freedom of the web, but so does its weakness. Alongside books and articles written by the most authoritative experts on every possible subject of human knowledge, there are texts that are cobbled together, manipulated or invented. The historian Carlo Ginzburg said this admirably in his lectio magistralis when he received the prestigious Balzan Prize (several of its winners have also received a Nobel Prize) in September 2011:

Some have said that the Internet is an instrument of democracy. Taken literally, this statement is false. We have to add: it is an instrument of potential democracy. The motto of the Internet can be summarized in the words, paradoxical and politically incorrect, pronounced by Jesus: “Whoever has will be given more” (Matthew, XIII, 12). To navigate in the Internet, to distinguish the pearl from the sow’s ear, you already have to have had access to culture—an access which normally (and I speak from personal experience) is associated with social privilege. The Internet, which potentially could be an instrument that could attenuate cultural inequalities, in the immediate, exasperates them. Schools need the Internet, of course, but the Internet, to be used according to its potential (let’s say realistically one-millionth of its capacity), needs state schools that really teach.

Bibliography

  1. Afzal, M.A. et al. (2006), Absence of Detectable Measles Virus Genome Sequence in Blood of Autistic Children Who Have Had Their MMR Vaccination During the Routine Childhood Immunization Schedule of UK, “Journal of Medical Virology”, 78(5), pp. 623–30.CrossRefGoogle Scholar
  2. Baggs, J. et al (2011), The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety, “Pediatrics”, 127 Suppl 1, pp. S45–53.CrossRefGoogle Scholar
  3. Baird, G. et al. (2008), Measles Vaccination and Antibody Response in Autism Spectrum Disorders, “Archive Disease in Childhood”, October, 93(10), pp. 832–37.CrossRefGoogle Scholar
  4. Baker JP, Katz SL, Childhood vaccine development: an overview. Pediatr Res. 2004 Feb;55(2):347–56. Epub 2003 Nov 19.CrossRefGoogle Scholar
  5. Bandolier, Independent Evidence-Based Thinking About Health Care, Oxford University [authors not mentioned], “Extra Number on MMR Vaccination and Autism”, April 2005, pp. 1–12.Google Scholar
  6. Bates, T. (2011), MMR Scare. In the Wake of Wakefield, “BMJ”, 342, p. d806.CrossRefGoogle Scholar
  7. Battistella, M. et al. (2013), Vaccines and Autism: A Myth to Debunk?, “Igiene e Sanità Pubblica”, 69 (5), pp. 585–96.Google Scholar
  8. Bauer, M. (1995), Resistance to New Technology: Nuclear Power, Information Technology and Biotechnology, Cambridge University Press, Cambridge, New York.CrossRefGoogle Scholar
  9. Berkes, E.A. (2003), Anaphylactic and Anaphylactoid Reactions to Aspirin and Other NSAIDS, “Clinical Reviews in Allergy & Immunology”, 24 (2), pp. 137–48.CrossRefGoogle Scholar
  10. Bernsen, R.M. et al. (2006), Early Life Circumstances and Atopic Disorders in Childhood, “Clin Exp Allergy”, 36 (7), pp. 858–65.CrossRefGoogle Scholar
  11. Bessi, A. et al. (2015), Science vs Conspiracy: Collective Narratives in the Age of Misinformation, “PLoS ONE”, 10(2), e0118093.CrossRefGoogle Scholar
  12. Blumberg, S.J. et al. (2013), Changes in Prevalence of Parent-Reported Autism Spectrum Disorder in School-Aged US Children: 2007 to 2011-2012, “National Health Statistics Report”, (65), pp. 1-11.Google Scholar
  13. Brown K.F., Long S.J., et al., (2012), UK parents’ decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: A qualitative analysis, “Vaccine”, 30 (10). pp. 1855–1864.CrossRefGoogle Scholar
  14. Bucci, E. (2015), Cattivi Scienziati. La frode nella ricerca scientifica, Add Editore, Torino.Google Scholar
  15. Burnett, J.C. (1884), Vaccinosis and Its Cure by Thuja; With Remarks On Homeoprophylaxis, Homoeopathic Publishing Co., LondonGoogle Scholar
  16. Busse, J.W., Morgan, L. et al. (2005), Chiropractic antivaccination arguments, “J Manipulative Physiol Ther”, 28, pp. 367–73.CrossRefGoogle Scholar
  17. Byford, J. (2011), Conspiracy Theories: A Critical Introduction, Palgrave Macmillan, London, New York.CrossRefGoogle Scholar
  18. Calvert N, Ashton JR, Garnett E., Mumps outbreak in private schools: public health lessons for the post-Wakefield era. Lancet. 2013 May 11;381(9878):1625–6.CrossRefGoogle Scholar
  19. Chow, Y.K.M, Danchin et al. (2017), Parental attitudes, beliefs, behaviours and concerns towards childhood vaccinations in Australia: A national online survey, “Australian Family Physician”, 46 (3), pp. 145–151.Google Scholar
  20. Conforti, M., G. Corbellini e G. Gazzaniga (2012), Dalla cura alla scienza. Malattia, salute e società nel mondo occidentale, Milano, EncycloMedia.Google Scholar
  21. Corbellini, G. (2013), Scienza, Bollati Boringhieri, Torino.Google Scholar
  22. D’Souza, Y., E. Fombonne and B.J. Ward (2006), No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells From Children With Autism Spectrum Disorder, “Pediatrics”, 118(4), pp. 1664–75CrossRefGoogle Scholar
  23. Dales, L., S.J. Hammer and N.J. Smith (2001), Time Trends in Autism and in MMR Immunization Coverage in California, “JAMA”, March, 7, 285(9), pp. 1183–85.CrossRefGoogle Scholar
  24. Deer, B. (2004), Revealed: MMR Research Scandal, “The Sunday Times”, 22 February.Google Scholar
  25. Deer, B. (2011a), How the Case against the MMR Vaccine Was Fixed, “BMJ”, 342, c5347.CrossRefGoogle Scholar
  26. Deer, B. (2011b), How the Vaccine Crisis Was Meant to Make Money, “BMJ”, 342.CrossRefGoogle Scholar
  27. Deisher, T.A. et al. (2015), Epidemiologic And Molecular Relationship Between Vaccine Manufacture and Autism Spectrum Disorder Prevalence, “Issues in Law & Medicine”, 30 (1), pp. 47–70.Google Scholar
  28. DeStefano, F., C.S. Price and E.S. Weintraub (2013), Increasing Exposure to Antibodystimulating Proteins and Polysaccharides in Vaccines is Not Associated With Risk of Autism, “Journal of Pediatrics”, August 163(2), p. 5617.Google Scholar
  29. DeStefano F, Thompson WW., MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines. 2004 Feb;3(1):19–22.CrossRefGoogle Scholar
  30. Diel, R. et al. (2014), Costs of Tuberculosis Disease in the European Union: A Systematic Analysis and Cost Calculation, “European Respiratory Journal”, 43 (2), pp. 554–65.CrossRefGoogle Scholar
  31. Douglas R.G., Samant V.B. (2017), The Vaccine Industry. In: J.L. Schwartz, A.L. Caplan (Eds.), Vaccination Ethics and Policy. An Introduction with Readings, MIT University Press, Cambridge, MA.Google Scholar
  32. Downey, L., Tyree, P.T. et al. (2010), Pediatric vaccination and vaccine-preventable disease acquisition: Associations with care by complementary and alternative medicine providers, “Matern Child Health J.”,; 14(6): pp. 922–30.CrossRefGoogle Scholar
  33. Ethgen O., Baron-Papillon F., Cornier M. (2016), How much money is spent on vaccines across Western European countries?, “Human Vaccines & Immunotherapeutics”, 12 (8), pp. 2038–2045.CrossRefGoogle Scholar
  34. Fontanella, C.A. et al. (2015), Widening Rural-Urban Disparities in Youth Suicides, United States, 1996-2010, “JAMA Pediatrics”, 169 (5), pp. 466–73.CrossRefGoogle Scholar
  35. Gadad, B.S. et al. (2015), Administration of Thimerosal-Containing Vaccines to Infant Rhesus Macaques Does Not Result in Autism-Like Behavior Or Neuropathology, “Proceedings of the National Academy of Sciences”, 112 (40), pp. 12.498-503.Google Scholar
  36. Galazka, A. and S. Dittmann (2000), Implications of the Diphtheria Epidemic in the Former Soviet Union for Immunization Programs, Journal of Infectious Diseases, 181 (Supplement 1), S244–S248.CrossRefGoogle Scholar
  37. Gentile, I. et al. (2013), Response to Measlesmumpsrubella Vaccine in Children with Autism Spectrum Disorders, “Vivo MayJun”, 27(3), p. 37.782.Google Scholar
  38. Gigerenzer, G. (2015), Imparare a rischiare: come prendere decisioni giuste, Cortina, Milano (original edition: Risk Savvy: How to Make Good Decisions, 2014).Google Scholar
  39. Ginzburg, C. (2006), Il filo e le tracce. Vero, falso, finto. Feltrinelli, Milano (Engl. transl.: Threads and Traces: True False Fictive. University of California Press, 2012).Google Scholar
  40. Godlee, F., J. Smith, H. Marcovitch (2011), Wakefield’s Article Linking Mmr Vaccine and Autism Was Fraudulent, “BMJ”, 342.CrossRefGoogle Scholar
  41. Greenberg J., Dube E., Driedger M. (2017), Vaccine Hesitancy: In Search of the Risk Communication Comfort Zone, “PLoS Curr”, 9.Google Scholar
  42. Grignolio, A. (2010), (ed. by), Immunology Today. Three Historical Perspectives Under Three Theoretical Horizons, Bononia Univeristy Press, Bologna.Google Scholar
  43. Grignolio, A. (2015), L’influenza di alcune idee relativiste sull’antiscientismo. In M. Cappato (ed.), Fra scienza e politica. Il difficile cammino della libertà di ricerca, Carocci editore, Rome, pp. 125–37.Google Scholar
  44. Grignolio, A., Mishto M. et al. (2014), Towards a Liquid Self: How Time, Geography, and Life Experiences Reshape the Biological Identity, “Frontiers in Immunology”, 5, p. 153.Google Scholar
  45. Grmek, M.D. (1985) Le malattie all’alba della civiltà occidentale, Il Mulino, Bologna (original edition Les maladies à l’aube de la civilisation occidentale, 1983).Google Scholar
  46. Gruber, C. et al. (2008), Early Atopic Disease and Early Childhood Immunization – Is There A Link?, “Allergy”, 63 (11), pp. 1464–72.CrossRefGoogle Scholar
  47. Haidt, J. (2013), Menti tribali: perché le brave persone si dividono su politica e religione, Codice edizioni, Torino (original edition The Righteous Mind: Why Good People Are Divided by Politics and Religion, 2012).Google Scholar
  48. Hansen, S.N., D.E. Schendel e E.T. Parner (2015), Explaining the Increase in the Prevalence of Autism Spectrum Disorders: The Proportion Attributable to Changes in Reporting Practices, “JAMA Pediatrics”, 169 (1), pp. 56–62.CrossRefGoogle Scholar
  49. Heck Hd, Casanova M, The implausibility of leukemia induction by formaldehyde: a critical review of the biological evidence on distant-site toxicity. Regul Toxicol Pharmacol. 2004 Oct;40(2):92–106.CrossRefGoogle Scholar
  50. Hobson-West P. (2007), ‘Trusting blindly can be the biggest risk of all’: organized resistance to childhood vaccination in the UK, “Sociology of Health and Illness”, 29(2), pp. 198–215.CrossRefGoogle Scholar
  51. Hogg, M.A. e D.L. Blaylock (2011), Extremism and the Psychology of Uncertainty, Wiley-Blackwell, Malden, MA.Google Scholar
  52. Honda, H., Y. Shimizu e M. Rutter (2005), No Effect of MMR Withdrawal on the Incidence of Autism: A Total Population Study, “Journal of Child Psychology Psychiatry”, 46(6), pp. 572–79.CrossRefGoogle Scholar
  53. Hornig, M. et al. (2008), Lack of Association Between Measles Virus Vaccine and Autism With Enteropathy: A Case-Control Study, “PLoS One”, 4,3(9), e3140.Google Scholar
  54. Iqbal, S. et al. (2013), Number of Antigens in Early Childhood Vaccines and Neuropsychological Outcomes at Age 7-10 Years, “Pharmacoepidemiology and Drug Safety”, December, 22(12), p. 126.370.CrossRefGoogle Scholar
  55. Jain A, Marshall J et al., Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA. 2015 Apr 21;313(15):1534–40.CrossRefGoogle Scholar
  56. Jervis, G. (2014), Contro il sentito dire. Psicoanalisi, psichiatria e politica, Bollati Boringhieri, Torino.Google Scholar
  57. Jick, H., J.A. Kaye e C. Black (2003), Changes in Risk of Autism in the UK for Birth Cohorts 1990-1998, “Epidemiology”, 14(5), pp. 630–32.CrossRefGoogle Scholar
  58. Johnson, N.P. and J. Mueller (2002), Updating the Accounts: Global Mortality of the 1918-1920 “Spanish” Influenza Pandemic, “Bulletin of the History of Medicine”, 76 (1), pp. 105–15.CrossRefGoogle Scholar
  59. Jolley, D. and K.M. Douglas (2013), The Social Consequences of Conspiracism: Exposure to Conspiracy Theories Decreases Intentions to Engage in Politics and to Reduce one’s Carbon Footprint, “British Journal of Psychology”, 105 (1), pp. 35–56.CrossRefGoogle Scholar
  60. Kahan, D.M. et al. (2009), Cultural Cognition of the Risks and Benefits of Nanotechnology, “Nature Nanotechnology”, 4(2), pp. 87–91.CrossRefGoogle Scholar
  61. Kahan, D.M., H. Jenkins-Smith and D. Braman (2011), Cultural Cognition of Scientific Consensus, “Journal of Risk Research”, 14, pp. 147–74.CrossRefGoogle Scholar
  62. Kata, A. (2010), A Postmodern Pandora’s Box: Anti-Vaccination Misinformation on the Internet, “Vaccine”, 28 (7), pp. 1709–16.CrossRefGoogle Scholar
  63. Kaye, J.A., M.M. Melero-Montes and H. Jick (2001), Mumps, Measles, and Rubella Vaccine and the Incidence of Autism Recorded by General Practitioners: A Time-Trend Analysis, “BMJ”, 322, pp. 460–63.CrossRefGoogle Scholar
  64. Keith, L.S., D.E. Jones and C.H. Chou (2002), Aluminum Toxicokinetics Regarding Infant Diet and Vaccinations, “Vaccine”, 20 Suppl. 3, pp. S13–17.CrossRefGoogle Scholar
  65. Kelemen, D. et al. (2005), Why Things Happen: Teleological Explanation in Parent-Child Conversations, “Developmental Psychology”, 41(1), pp. 251–64.CrossRefGoogle Scholar
  66. Kelemen, D. and E. Rosset (2009), The Human Function Compunction: Teleological Explanation in Adults, “Cognition”, 111(1), pp. 138–43.CrossRefGoogle Scholar
  67. Kelemen, D., J. Rottman and R. Seston (2012), Professional Physical Scientists Display Tenacious Teleological Tendencies: Purpose-Based Reasoning As A Cognitive Default, “Journal Experimental Psychology”, January 142(4), pp. 1074–83.CrossRefGoogle Scholar
  68. Kruglanski, A.W. and D.M. Webster (1996), Motivated Closing of the Mind: “Seizing” and “Freezing”, “Psychology Review”, 103(2), pp. 263–83.CrossRefGoogle Scholar
  69. Kutty, P.K. et al. (2010), Seroprevalence of Antibody to Mumps Virus in The US Population, 1999-2004, “The Journal of Infection Diseases”, 202 (5), pp. 667–74.CrossRefGoogle Scholar
  70. Lanza F.L., F.K. Chan and E.M. Quigley (2009), Guidelines for Prevention of Nsaid-Related Ulcer Complications, “The American Journal of Gastroenterology”, 104 (3), pp. 728–38.CrossRefGoogle Scholar
  71. Le Couteur P. and J. Burreson (2006), I bottoni di Napoleone: come 17 molecole hanno cambiato la storia, Longanesi, Milano (oroiginal edition, Napoleon’s Buttons: How 17 Molecules Changed History, 2003).Google Scholar
  72. Leman, P.J. and M. Cinnirella (2013), Beliefs in Conspiracy Theories and the Need for Cognitive Closure, “Frontiers in Psychology”, 4.Google Scholar
  73. Leon, D.A. et al. (1997), Huge Variation in Russian Mortality Rates 1984-94: Artefact, Alcohol, Or What?, “The Lancet”, 350 (9075), pp. 383–88.CrossRefGoogle Scholar
  74. Lewandowsky, S., et al. (2013), The Role of Conspiracist Ideation and Worldviews in Predicting Rejection of Science, “PLoS ONE”, 8(10), p. e75637.CrossRefGoogle Scholar
  75. Lidsky, T.I. (2014), Is the Aluminum Hypothesis Dead?, “Journal of Occupational and Environmental Medicine”, 56(5 Suppl), pp. S73-S79.CrossRefGoogle Scholar
  76. Madsen, K.M. et al. (2002), MMR Vaccination And Autism. A Population-Based Follow-Up Study, Ugeskr Laeger, 164 (49), pp. 5741–44 (I was only able to read the data and the conclusions in English of this study in Danish).Google Scholar
  77. Madsen, K.M. et al. (2003), Thimerosal and the Occurrence of Autism: Negative Ecological Evidence From Danish Population-Based Data, “Pediatrics”, 112 (3 Pt 1), pp. 604–606.CrossRefGoogle Scholar
  78. Marx, J. (2010), Rosen’s Emergency Medicine: Concepts and Clinical Practice, 7th edition, Mosby/Elsevier, Philadelphia, Vol. I, p. 2422.CrossRefGoogle Scholar
  79. McNeil, M.M. et al. (2014), The Vaccine Safety Datalink: Successes and Challenges Monitoring Vaccine Safety, “Vaccine”, 32 (42), pp. 5390–5398.CrossRefGoogle Scholar
  80. Merrick, J., I. Kandel and M. Morad (2004), Trends in Autism, “International Journal of Adolescent Medicine and Health”,16(1), pp. 75–78.Google Scholar
  81. Messerli, F.H. (2012), Chocolate Consumption, Cognitive Function, and Nobel Laureates, “New England Journal of Medicine”, 367 (16), pp. 1562–1564.CrossRefGoogle Scholar
  82. Mitkus, R.J. et al. (2011), Updated Aluminum Pharmacokinetics Following Infant Exposures Through Diet And Vaccination, “Vaccine”, 29 (51), pp. 9538–43.CrossRefGoogle Scholar
  83. Montana, M. et al. (2010), Safety Review: Squalene and Thimerosal In Vaccines, “Therapie”, 65 (6), pp. 533–41.CrossRefGoogle Scholar
  84. Munro, G.D. and P.H. Ditto (1997), Biased Assimilation, Attitude Polarization, and Affect in Reactions to Stereotype-Relevant Scientific Information, “Personality and Social Psychology Bulletin”, 23(6), pp. 636–53.CrossRefGoogle Scholar
  85. Murch, S.H. et al. (2004), Retraction of an Interpretation, “Lancet”, 363 (9411), p. 750.CrossRefGoogle Scholar
  86. Namer M, Luporsi E, Gligorov J, Lokiec F, Spielmann M, L’utilisation de déodorants/antitranspirants ne constitue pas un risque de cancer du sein. Bull Cancer. 2008 Sep;95(9):871–80.Google Scholar
  87. Nassar, N. et al. (2009), Autism Spectrum Disorders in Young Children: Effect of Changes in Diagnostic Practices, “International Journal of Epidemiology”, 38 (5), pp. 1245–54.CrossRefGoogle Scholar
  88. Natarajan AT, Darroudi F, Bussman CJ, van Kesteren-van Leeuwen AC., Evaluation of the mutagenicity of formaldehyde in mammalian cytogenetic assays in vivo and vitro. Mutat Res. 1983 Dec;122(3–4):355–60.CrossRefGoogle Scholar
  89. Nyhan, B. et al. (2014), Effective Messages in Vaccine Promotion: A Randomized Trial, “Pediatrics”, 133 (4), pp. e835–842.CrossRefGoogle Scholar
  90. Offit PA, Jew RK. Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?. Pediatrics. 2003 Dec;112(6 Pt 1):1394–7.CrossRefGoogle Scholar
  91. Offit, P.A. (2005), Why are pharmaceutical companies gradually abandoning vaccines?, “Health Aff.”, 24 (3), pp. 622–630.CrossRefGoogle Scholar
  92. Offit, P.A. (2015), Deadly Choices. How the Anti-Vaccine Movement Threatens Us All, New York, Basic Books.Google Scholar
  93. Ozawa S., Portnoy A., et al. (2016), Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States, “Health Affairs”, 35 (11), pp. 2124–2132.CrossRefGoogle Scholar
  94. Pegorie, M et al. (2014), Measles Outbreak in Greater Manchester, England, October 2012 to September 2013: Epidemiology and Control, “Euro Surveill”, 18(49).Google Scholar
  95. Peltola, H. et al. (1998), No Evidence for Measles, Mumps, And Rubella Vaccine-Associated Inflammatory Bowel Disease or Autism in A 14-Year Prospective Study, “Lancet”, May 2, 351(9112), pp. 1327, 1328.CrossRefGoogle Scholar
  96. Poland, G.A. and R. Spier (2010), Fear, Misinformation, And Innumerates: How The Wakefield Paper, The Press, And Advocacy Groups Damaged The Public Health, “Vaccine”, 28 (12), pp. 2361, 2362.CrossRefGoogle Scholar
  97. Reich J.A. (2016), Calling the shots : why parents reject vaccines, New York, New York University Press.Google Scholar
  98. Roggendorf H, Mankertz A, Kundt R, Roggendorf M., Spotlight on measles 2010: measles outbreak in a mainly unvaccinated community in Essen, Germany, March-June 2010. Euro Surveill. 2010 Jul 1;15(26). pii: 19605.Google Scholar
  99. Roehr, B. (2013), Study Finds No Association Between Vaccines and Autism, “British Medical Journal”, 3 April; 346, p. f2095.Google Scholar
  100. Sandler, B.P. (1941), The Production of Neuronal Injury And Necrosis With the Virus of Poliomyelitis in Rabbits During Insulin Hypoglycemia, “The American Journal of Pathology”, 17 (1), pp. 69–85.Google Scholar
  101. Schmitz, R. et al. (2011), Vaccination Status and Health in Children and Adolescents, “Dtsch Arztebl International”, 108 (7), pp. 99–104.Google Scholar
  102. Silvestrini, B. (2014), Il farmaco moderno: un patto esemplare fra uomo e natura, Roma, Carocci.Google Scholar
  103. Singh G. and G. Triadafilopoulos (1999), Epidemiology of Nsaid Induced Gastrointestinal Complications, “Journal of Rheumatology Suppl.”, 56, pp. 18–24.Google Scholar
  104. Singh, G.K. and M. Siahpush (2014), Widening Rural-Urban Disparities in All-Cause Mortality and Mortality from Major Causes of Death in the USA, 1969-2009, “Journal of Urban Health”, 91 (2), pp. 272–92.Google Scholar
  105. Til HP, Woutersen RA, Feron VJ, Hollanders VH, Falke HE, Clary JJ. Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol. 1989 Feb;27(2):77–87.CrossRefGoogle Scholar
  106. Tannous, L.K., G. Barlow e N.H. Metcalfe (2014), A Short Clinical Review of Vaccination Against Measles, “JRSM Open”, 5 (4).CrossRefGoogle Scholar
  107. Taylor, B. (2006), Vaccines and the Changing Epidemiology of Autism, “Child: Care, Health and Development”, 32(5), pp. 511–19.Google Scholar
  108. Taylor, B. et al. (1999). Autism and Measles, Mumps, and Rubella Vaccine: No Epidemiological Evidence For a Causal Association, “Lancet”, June 12, 353(9169), pp. 2026–29.CrossRefGoogle Scholar
  109. Thompson, N.P. et al. (1995), Is Measles Vaccination a Risk Factor for Inflammatory Bowel Disease?, “Lancet”, 345 (8957), pp. 1071–74.CrossRefGoogle Scholar
  110. Uno Y. et al. (2015), Early Exposure to the Combined Measles-Mumps-Rubella Vaccine and Thimerosal-Containing Vaccines and Risk of Autism Spectrum Disorder, “Vaccine”, 33 (21), pp. 2511–16.CrossRefGoogle Scholar
  111. Verstraeten T. et al. (2003), Safety of Thimerosal-Containing Vaccines: A Two-Phased Study of Computerized Health Maintenance Organization Databases, “Pediatrics”, 112 (5), pp. 1039–48.Google Scholar
  112. Vivancos, R. et al. (2012), An Ongoing Large Outbreak of Measles in Merseyside, England, January to June 2012, “Euro Surveill”, 17(29).Google Scholar
  113. Vozza, L., D’Incalci, M., & Gescher, A. (2017). How medicines are born: The imperfect science of drugs. London, Hackensack, NJ : World Scientific Publishing Europe Ltd.Google Scholar
  114. Wakefield, A.J. (2003), Measles, Mumps, and Rubella Vaccination and Autism. Comment to the Editor, “The New England Journal of Medicine”, 348 (10), p. 952.Google Scholar
  115. Wakefield A.J. et al. (1993), Evidence of Persistent Measles Virus Infection in Crohn’s Disease, “Journal of Medical Virology”, 39 (4), pp. 345–53.CrossRefGoogle Scholar
  116. Wakefield, A.J. et al. (1998), Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children, “Lancet”, 351 (9103), pp. 637–41.Google Scholar
  117. Wood, M.J., K.M. Douglas and R.M. Sutton (2012), Dead and Alive: Beliefs in Contradictory Conspiracy Theories, “Social Psychological and Personality Science”, 3 (6), pp. 767–73.CrossRefGoogle Scholar
  118. Yaqub O., Castle-Clarke S. et al. (2014), Attitudes to vaccination: A critical review, “Social Science & Medicine”, 112, pp. 1–11.CrossRefGoogle Scholar
  119. Young A., Chaudhry H. et al.. (2015), A Census of Actively Licensed Physicians in the United States, 2014, “Journal of Medical Regulation”, 101 (2): pp. 8–23.CrossRefGoogle Scholar
  120. Zoja L. (2011), Paranoia: la follia che fa la storia. Torino, Bollati Boringhieri (English translation: Paranoia The madness that makes history. Florence, Taylor and Francis, 2017).Google Scholar
  121. Zollo, F. et al. (2015), Debunking in a World of Tribes, (in press) available in preprint arXiv:1510.04267.Google Scholar
  122. Zuzak, T.J. et al. (2008), Attitudes Towards Vaccination: Users of Complementary and Alternative Medicine Versus Non-Users, “Swiss Medical Weekly”, 138 (47–48), pp. 713–18.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Andrea Grignolio
    • 1
  1. 1.Unit and Museum of History of Medicine, Department of Experimental MedicineSapienza University of RomeRomeItaly

Personalised recommendations